Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-282735

Chief Operating Officer sold 2,175 shares at $20.00 ($43,500)

  • Chief Operating Officer acquired 2,175 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Champoux Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-23 Exercise or conversion : show line 1 in the form 10b5-1 +2,175 $3.98 $8,657 64,546 D
2026-06-23 Sale : show line 2 in the form 10b5-1 −2,175 $20.00 $43,500 62,371 D
Open-market sales · 2,175 sh · avg $20.00 · $43,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-23 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −2,175 31,298 D
Loading xslF345X06/ownership.xml…